ProQR Partners With Ginkgo to Boost AI Drug Discovery

ProQR Therapeutics has announced the formation of an AI advisory board and a new partnership with Ginkgo Bioworks as part of a broader strategy to leverage artificial intelligence in drug discovery. The initiative is designed to enhance ProQR's discovery capabilities, with the Ginkgo collaboration serving as a key component of the company's evolving AI-driven approach to therapeutics development.